Global Home Healthcare Market Overview, 2023-28

The Global Home Healthcare market is anticipated to cross USD 450 Billion by 2028, increasing from USD 289 Billion in 2022.

Featured Companies

  • 1. Beckton Dickinson
  • 2. Sanofi S.A.
  • 3. Medtronic plc
  • 4. B. Braun Melsungen AG
  • 5. Terumo Corporation
  • 6. Nipro Corporation
  • 7. Huntsman International LLC
  • 8. Novo Nordisk A/S
  • 9. F. Hoffmann-La Roche AG,
  • More...

Home healthcare refers to a number of medical treatments that can be delivered to a patient in the comfort of their own home to treat a sickness or accident. The alternatives for receiving home health care services for a patient are nearly limitless. Depending on the circumstances of the specific patient, care might range from nursing to specialized medical treatments such as laboratory workups. The doctor will establish the treatment strategy and any home treatments that the patient may require. Depending on the patient's health, the duration of home healthcare might range from brief to long. Home healthcare may or may not be prescribed by the doctor. In cases where it is prescribed by the doctor, these services are generally covered by the insurance company. Home healthcare also includes gadgets such as blood pressure monitors, glucose monitors, and other therapeutic and diagnostic devices. The scope of the home healthcare industry includes both products and services. The rising proportion of geriatric patients worldwide, particularly in industrialized nations such as Germany, France, Japan, and the United States, is seen as a major driving force in the growth of the home healthcare market. Home healthcare refers to a wide range of healthcare treatments provided to patients in their homes. These services mostly involve severe illness and injury monitoring, intravenous and nutrition therapy, wound care, respiratory therapy, and other therapies. The home healthcare market share is predicted to expand because to the high quality of care delivered at a lower cost than services provided in hospitals or skilled nursing facilities. Rising demand for home healthcare services is being driven by increased awareness of home care facilities and disposable income. Bedridden and elderly patients prefer home healthcare services and products because they prevent readmission to the hospital and have a greater recovery rate than in-hospital treatment. Companies are increasingly concentrating their efforts in previously untouched markets such as India and China. For example, Apollo Homecare provides long-term plans for ortho rehab, heart rehab, neuro rehab, lung rehab, mother and infant care, and geriatric care. Medical supervision and specialized healthcare services are part of these programs. Furthermore, technological advancements are projected to promote the expansion of the home healthcare industry. Active home telemonitoring equipment, for example, can assist in gathering vital signs and symptoms, which aids the home health agency. People choose devices that can be utilized whenever they want. This gives patients a sense of comfort and flexibility, which increases demand. For example, insulin delivery devices, home dialysis equipment, intravenous pumps, and blood pressure monitors. According to the research report, “Global Home Healthcare Market Overview, 2023-28” published by Bonafide Research, the market is anticipated to cross USD 450 Billion by 2028, increasing from USD 289 Billion in 2022. The market is expected to grow with more than 7.86% CAGR by 2023-28. Many individuals express a strong preference for aging in place, meaning they prefer to remain in their homes as they age rather than moving to institutional settings such as nursing homes or assisted living facilities. Home healthcare services enable seniors to receive the necessary medical care and support while maintaining independence and a sense of familiarity. This preference is a significant driver of the growth in the home healthcare market. Advancements in technology, including telehealth, wearable devices, and remote monitoring tools, have played a crucial role in the growth of home healthcare. Telehealth services allow healthcare professionals to conduct virtual consultations, monitor patients remotely, and provide timely interventions. Wearable devices and smart healthcare technologies contribute to better patient outcomes by enabling continuous monitoring and management of health conditions within the home environment. The COVID-19 pandemic has accelerated the adoption of home healthcare services. Lockdowns, social distancing measures, and concerns about exposure to the virus in healthcare facilities led to a surge in demand for remote healthcare solutions. Telehealth, in particular, experienced widespread acceptance, and the pandemic highlighted the importance of home-based care for managing various health conditions while minimizing the risk of infection. In addition to that, the healthcare industry is undergoing a shift from fee-for-service models to value-based care, emphasizing patient outcomes and quality of care. Home healthcare aligns well with this transition, as it focuses on delivering personalized and patient-centric care that contributes to improved outcomes. The emphasis on value-based care models has driven collaborations and partnerships between healthcare providers and home healthcare services to enhance overall healthcare delivery. There is a growing recognition of the importance of patient-centric care models, which prioritize individual preferences, needs, and involvement in the decision-making process. Home healthcare allows for more personalized and patient-centered care, fostering a stronger connection between healthcare providers and patients. This shift in approach contributes to higher patient satisfaction and better overall healthcare experiences.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

The Asia-Pacific region is witnessing significant growth in the home healthcare market due to a myriad of factors driving the increased adoption of home-based care services. One key factor is the demographic landscape, with a rapidly aging population in many countries across the region. As the elderly population grows, there is a rising demand for healthcare solutions that provide personalized and convenient care in the familiar environment of one's home. Additionally, the increasing prevalence of chronic diseases in the region has fueled the need for ongoing and cost-effective healthcare services, which home healthcare effectively addresses. Technological advancements, including the widespread availability of smartphones and internet connectivity, have facilitated the adoption of telehealth solutions, enabling patients to access medical consultations and monitoring from the comfort of their homes. Moreover, the COVID-19 pandemic has accelerated the acceptance of remote healthcare services, contributing to the surge in demand for home healthcare in Asia-Pacific. Governments and healthcare providers in the region are recognizing the potential of home-based care to alleviate the strain on traditional healthcare systems and improve overall accessibility to quality healthcare services. The combination of demographic trends, technological advancements, and the lessons learned from the pandemic has positioned the Asia-Pacific home healthcare market for robust growth as it continues to meet the evolving healthcare needs of its diverse and expanding population. Home healthcare services are experiencing remarkable growth within the home healthcare market due to a confluence of factors. Primarily, the aging global population is a driving force, as seniors increasingly prefer the comfort and familiarity of their homes for receiving healthcare services. This demographic trend has led to an upsurge in demand for home-based care to address the complex healthcare needs associated with aging. Furthermore, technological advancements, such as telehealth and remote monitoring, have revolutionized healthcare delivery, allowing providers to extend their services directly to patients' homes. The integration of these technologies facilitates virtual consultations, continuous monitoring, and personalized care plans, contributing to the overall appeal and effectiveness of home healthcare services. Cost-effectiveness is another crucial factor propelling growth, as home-based care offers an economically viable alternative to institutional settings, aligning with the broader healthcare industry's focus on cost containment. The recent global health crisis has further accelerated this growth, with the COVID-19 pandemic highlighting the importance of minimizing exposure risks in healthcare facilities and fostering a rapid acceptance of telehealth solutions. In essence, the expansion of home healthcare services can be attributed to a combination of demographic shifts, technological innovation, cost considerations, and the evolving preferences of patients for personalized, home-based care. Respiratory diseases are increasingly becoming a focal point in the home healthcare market due to a combination of factors that emphasize the need for effective and accessible care. The prevalence of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, is on the rise globally. As these diseases often require continuous monitoring and management, home healthcare services present a practical and patient-friendly solution. Advances in technology, such as portable oxygen concentrators, home ventilators, and remote monitoring devices, empower individuals with respiratory conditions to receive specialized care within the comfort of their homes. Telehealth solutions enable remote consultations with respiratory therapists and healthcare providers, offering real-time guidance on symptom management and treatment adjustments. The COVID-19 pandemic has further underscored the importance of home-based respiratory care, as individuals with respiratory illnesses face heightened risks in healthcare facilities. The home healthcare market is thus witnessing a growth trajectory driven by the increasing incidence of respiratory diseases, technological innovations, and a broader shift toward personalized, patient-centric care for managing respiratory conditions in a home setting.

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Market Drivers • COVID-19 pandemic: The pandemic has heightened the awareness of the importance of remote healthcare services and home-based care, as people seek alternatives to traditional healthcare settings to minimize the risk of exposure to the virus. Home healthcare services, such as virtual consultations, remote monitoring, and home-based testing, have gained prominence during this period, accelerating the adoption of telehealth solutions and reshaping the way healthcare is delivered globally. • Increasing prevalence of chronic diseases: Conditions such as diabetes, cardiovascular diseases, and respiratory disorders require continuous monitoring and management, making home healthcare a preferred option for patients. The ability to receive care in the comfort of one's home not only improves the quality of life for individuals with chronic illnesses but also contributes to the overall efficiency of healthcare delivery by reducing the burden on traditional healthcare facilities.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Market Challenges • Digital divide, particularly in underserved or rural areas: Access to reliable internet connectivity and digital devices is crucial for the effective implementation of telehealth services and remote monitoring. Disparities in technology access create barriers for certain populations, limiting their ability to benefit from home healthcare solutions. Bridging this digital divide requires concerted efforts from healthcare providers, policymakers, and technology companies to ensure equitable access to home healthcare services across diverse socioeconomic and geographic backgrounds. • Interoperability issues among different healthcare systems and electronic health records: Standardizing data formats and ensuring interoperability between various platforms are essential for creating a cohesive and interconnected home healthcare ecosystem. Overcoming these interoperability challenges is crucial for enhancing care coordination, reducing medical errors, and providing comprehensive and integrated home healthcare services. Market Trends • The integration of artificial intelligence (AI) and machine learning (ML): These technologies enhance the ability to analyze vast amounts of healthcare data, enabling more accurate diagnostics, personalized treatment plans, and predictive analytics. AI-driven applications, such as predictive modeling for disease management and smart home monitoring, are contributing to the evolution of home healthcare services, offering more proactive and personalized care solutions. • Shift towards wearable medical devices and sensor technologies: Wearables, such as smartwatches and health monitoring devices, provide real-time data on vital signs and health parameters, enabling healthcare providers to track patients' conditions remotely. This trend is fostering the development of user-friendly and patient-centric devices that empower individuals to actively participate in their healthcare management, promoting a proactive approach to preventive care within the home healthcare landscape. Covid-19 Impacts Like many industries, the home healthcare market faced challenges related to supply chain disruptions and operational issues during the pandemic. The availability of medical equipment, personal protective equipment (PPE), and other essential supplies became a concern, impacting the delivery of home healthcare services. Healthcare providers had to adapt rapidly to new protocols and implement safety measures to ensure the well-being of both patients and healthcare professionals. Governments around the world responded to the increased demand for remote healthcare by implementing regulatory changes to facilitate the expansion of telehealth services. Temporary waivers and adjustments were introduced to ease restrictions on telehealth reimbursement and licensure requirements, encouraging the widespread adoption of virtual care. These regulatory changes are likely to have lasting effects on the home healthcare landscape, shaping the future integration of telehealth into standard healthcare delivery models. With hospitals facing capacity constraints and a focus on reserving resources for COVID-19 patients, there has been a heightened emphasis on home-based recovery and post-acute care. Home healthcare services, including skilled nursing, rehabilitation, and recovery support, have become instrumental in ensuring continuity of care for patients recovering from illnesses or surgeries while minimizing the risk of exposure to the virus in healthcare facilities. COVID-19 has acted as a catalyst for the adoption of digital health technologies in the home healthcare sector. Wearable devices, remote patient monitoring tools, and mobile health applications gained prominence as individuals became more conscious of monitoring their health and well-being. These technologies not only enable patients to actively participate in their care but also provide healthcare professionals with real-time data for better decision-making and early intervention. Key Developments • In June 2023, it was announced that Amedisys has agreed to combine with Optum, a company specializing in providing diversified health services. Amedisys provides personalized home health and hospice care services and performs over 11.2 million visits to patient homes annually. • In February 2023, OMRON Healthcare announced the addition of new educational components to its OMRON Connect mobile application. These include articles relating to study summaries and AFib identification, as well as pointers for behavioral and lifestyle changes to reduce risks of heart attack and stroke. • In May 2023, Medtronic announced that it had entered into an agreement to acquire EOFlow Co. Ltd., which manufactures the EOPatch tubeless, wearable, and fully disposable insulin delivery device. • In March 2023, Philips announced the launch of the Philips Virtual Care Management solutions and services portfolio, which has been designed to improve patient engagement and health outcomes through a more comprehensive telehealth approach. • In March 2023, Cue Health launched a suite of diagnostic test kits, providing access to accurate, reliable testing from their homes and making it easier for people to take control of their health. Considered in this report: • Geography: Global • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028 Aspects covered in this report: • Global Home Healthcare market with its value and forecast along with its segments • Region-wise Home Healthcare market analysis • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation Regions covered in the report • North America • Europe • Asia-Pacific • South America • Middle-East & Africa By Product and Services: • Therapeutic • TSM • Mobility • Services By Indication: • Cardiovascular Disorders & Hypertension • Cancer • Diabetes • Respiratory Diseases • Movement Disorders • Pregnancy • Hearing Disorders • Wound Care • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV) The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Home Healthcare industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

Companies Mentioned

  • Beckton Dickinson
  • Sanofi S.A.
  • Medtronic plc
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Huntsman International LLC
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche AG,
  • Fresenius Medical Care AG & Co. KGaA

Table of Contents

  • Table of Contents
  • 1. Executive Summary
  • 2. Market Dynamics
  • 2.1. Market Drivers & Opportunities
  • 2.2. Market Restraints & Challenges
  • 2.3. Market Trends
  • 2.4. Covid-19 Effect
  • 2.5. Supply chain Analysis
  • 2.6. Policy & Regulatory Framework
  • 2.7. Industry Experts Views
  • 3. Research Methodology
  • 3.1. Secondary Research
  • 3.2. Primary Data Collection
  • 3.3. Market Formation & Validation
  • 3.4. Report Writing, Quality Check & Delivery
  • 4. Market Structure
  • 4.1. Market Considerate
  • 4.2. Assumptions
  • 4.3. Limitations
  • 4.4. Abbreviations
  • 4.5. Sources
  • 4.6. Definitions
  • 5. Economic /Demographic Snapshot
  • 6. Global Home Healthcare Market Outlook
  • 6.1. Market Size By Value
  • 6.2. Market Share By Region
  • 6.3. Market Size and Forecast, By Geography
  • 6.4. Market Size and Forecast, By Product and Services
  • 6.5. Market Size and Forecast, By Indication
  • 7. North America Home Healthcare Market Outlook
  • 7.1. Market Size By Value
  • 7.2. Market Share By Country
  • 7.3. Market Size and Forecast, By Product and Services
  • 7.4. Market Size and Forecast, By Indication
  • 8. Europe Home Healthcare Market Outlook
  • 8.1. Market Size By Value
  • 8.2. Market Share By Country
  • 8.3. Market Size and Forecast, By Product and Services
  • 8.4. Market Size and Forecast, By Indication
  • 9. Asia-Pacific Home Healthcare Market Outlook
  • 9.1. Market Size By Value
  • 9.2. Market Share By Country
  • 9.3. Market Size and Forecast, By Product and Services
  • 9.4. Market Size and Forecast, By Indication
  • 10. South America Home Healthcare Market Outlook
  • 10.1. Market Size By Value
  • 10.2. Market Share By Country
  • 10.3. Market Size and Forecast, By Product and Services
  • 10.4. Market Size and Forecast, By Indication
  • 11. Middle East & Africa Home Healthcare Market Outlook
  • 11.1. Market Size By Value
  • 11.2. Market Share By Country
  • 11.3. Market Size and Forecast, By Product and Services
  • 11.4. Market Size and Forecast, By Indication
  • 12. Competitive Landscape
  • 12.1. Competitive Dashboard
  • 12.2. Business Strategies Adopted by Key Players
  • 12.3. Key Players Market Share Insights and Analysis, 2022
  • 12.4. Key Players Market Positioning Matrix
  • 12.5. Porter's Five Forces
  • 12.6. Company Profile
  • 12.6.1. Novo Nordisk A/S
  • 12.6.1.1. Company Snapshot
  • 12.6.1.2. Company Overview
  • 12.6.1.3. Financial Highlights
  • 12.6.1.4. Geographic Insights
  • 12.6.1.5. Business Segment & Performance
  • 12.6.1.6. Product Portfolio
  • 12.6.1.7. Key Executives
  • 12.6.1.8. Strategic Moves & Developments
  • 12.6.2. Sanofi S.A.
  • 12.6.3. Medtronic plc
  • 12.6.4. Terumo Corporation
  • 12.6.5. Becton, Dickinson and Company
  • 12.6.6. F. Hoffmann-La Roche AG
  • 12.6.7. B. Braun Melsungen AG
  • 12.6.8. Baxter International Inc.
  • 12.6.9. Nipro Corporation
  • 12.6.10. Fresenius Medical Care AG & Co. KGaA
  • 13. Strategic Recommendations
  • 14. Annexure
  • 14.1. FAQ`s
  • 14.2. Notes
  • 14.3. Related Reports
  • 15. Disclaimer

List of Table
Table 1 : Global Home Healthcare Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2 : Influencing Factors for Home Healthcare Market, 2022
Table 3: Top 10 Counties Economic Snapshot 2020
Table 4: Economic Snapshot of Other Prominent Countries 2020
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Home Healthcare Market Size and Forecast, By Geography (2017 to 2028F) (In USD Billion)
Table 7 : Global Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 8 : Global Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 9 : North America Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 10 : North America Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 11 : Europe Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 12 : Europe Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 13 : Asia-Pacific Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 14 : Asia-Pacific Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 15 : South America Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 16 : South America Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 17 : Middle East & Africa Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 18 : Middle East & Africa Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)

List of Figures
Figure 1: Global Home Healthcare Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 5: Global Home Healthcare Market Share By Region (2022)
Figure 6: North America Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 7: North America Home Healthcare Market Share By Country (2022)
Figure 8: Europe Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 9: Europe Home Healthcare Market Share By Country (2022)
Figure 10: Asia-Pacific Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 11: Asia-Pacific Home Healthcare Market Share By Country (2022)
Figure 12: South America Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 13: South America Home Healthcare Market Share By Country (2022)
Figure 14: Middle East & Africa Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 15: Middle East & Africa Home Healthcare Market Share By Country (2022)
Figure 16: Competitive Dashboard of top 5 players, 2022
Figure 17: Market Share insights of key players, 2022
Figure 18: Porter's Five Forces of Global Home Healthcare Market

Feed Phosphate Market Research FAQs

Home healthcare refers to a range of medical and non-medical services provided to individuals in their homes. It includes services such as nursing care, therapy, assistance with daily activities, and medical monitoring.

Home healthcare services encompass a variety of offerings, including skilled nursing, physical therapy, occupational therapy, personal care assistance, wound care, medication management, and even hospice care for end-of-life support.

Telehealth in home healthcare involves the use of technology to facilitate remote consultations, monitor patients' health conditions, and provide virtual healthcare services. It enhances accessibility and allows healthcare professionals to connect with patients without physical presence.

Home healthcare is tailored to address various medical conditions, including but not limited to cardiovascular disorders, diabetes, respiratory diseases, cancer, movement disorders, pregnancy-related care, hearing disorders, and wound care. It also extends to managing conditions like sleep disorders, kidney disorders, neurovascular diseases, and HIV.

Home healthcare is often more cost-effective than hospital or institutional care. It reduces the need for prolonged hospital stays, minimizes readmissions, and optimizes healthcare resources by providing care in a patient's home environment.

Home healthcare providers adhere to strict privacy regulations, including the Health Insurance Portability and Accountability Act (HIPAA) in the United States. They implement secure communication methods and ensure that patient information is handled confidentially.

Quality of care in home healthcare is maintained through adherence to regulatory standards, ongoing training for healthcare professionals, regular assessments, and feedback mechanisms. Accreditation and certification from relevant healthcare bodies also contribute to ensuring high-quality services.

Wearable devices and other technologies are integrated into home healthcare to monitor vital signs, track patient activities, and provide real-time data to healthcare professionals. This facilitates proactive management of health conditions and enhances overall care outcomes.
Logo

Global Home Healthcare Market Overview, 2023-28

Contact usWe are friendly and approachable, give us a call.